CATHERINE DUVAL: Open Payments
NPI 1891146940 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 29 payments from 11 companies in 2025. Trend: 2023 $263 · 2024 $395 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $331 |
| Janssen Biotech, Inc. | 3 | $172 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $56 |
| Amgen Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $36 |
| GENZYME CORPORATION | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| ABBVIE INC. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: Bimzelx, TREMFYA, ILUMYA, OTEZLA, MOUNJARO, DUPIXENT, Sotyktu, SKYRIZI.
Industry payments across NC — which companies pay providers there.
